In 2018, there was a nearly 50% increase in funding for research studies in Canada and the USA on the effects of Marijuana. Sex researchers are now starting to join the marijuana craze, evident in a recent study published in the Archives of Sexual Behavior that investigated the relationship between marijuana use and unsafe sexual practices.
Sexual Psychology researchers out of New York University acquired a sample of participants via Craigslist, who claimed to have had sex while high at some point during the last three months. These people were of different ages and genders, and were asked questions that focused on the differences between having sex after consuming marijuana and after drinking alcohol.
The responses varied greatly from person to person but there were some general similarities, with many reporting that marijuana and alcohol definitely had an influence over who they ended up having sex with. For most participants, alcohol’s impact was more negative than marijuana’s.
“With weed I know who I’m waking up with. With drinking, you don’t know. Once you start drinking, everybody looks good,”
said one 34-year-old woman.
The study found that there was clear differences between alcohol and Marijuana, with the former numbing your body and latter heightening your overall sexual experience. This included a finding that showed that while high in a sexual experience, body sensations on sexual organs showed an increase in sensitivity.
Orgasms were shown to increase in some cases by a factor of 5.
The orgasm on the left is one that happened without any cannabis in the system, while the one on the right was after taking an edible. As you can see, there is still that up-down motion of the pelvic floor tightening and relaxing, but the pattern is less consistent than the one on the left.
What does this mean for the main players in the THC industry?
Earlier this year, Canopy reached a deal with Constellation Brands (STZ) for a $4 billion investment, giving it a massive infusion of capital. And last month, Canopy Growth agreed to acquire Ebbu, a hemp research and development company. Canopy, at that time, also said that Ebbu’s advancements on R&D “apply directly to Canopy Growth’s hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities.”
From this, many analysts are suggesting that the marijuana and hemp powerhouses are posturing to trademark their CBD products now that Donald Trump has signed the bill. One emerging Cannabis company has possibly found a way past this. Profile Solutions Inc (OTC:PSIQ)instead has purchased one of the most well known brands in the Cannabis industry, that of Cheech & Chong Product Line. While these are currently only mens grooming products, they are already trade marked. Now, when their large scale growing operation goes operational (See Here), they will only have to put the CBD products under the banner of Cheech and Chong, and thus it would be trade marked.
Aphria announced Wednesday it has struck a deal with Insumos Medicos to provide the Paraguayan pharmaceutical company with medical-grade cannabis, the first such deal in the country. Paraguay will become Aphria’s third market in Latin America, following Argentina and Colombia, which follows PSIQ’s expansion into Latin America.